Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis (Kwan, et al, 2024)

20 abr.

Escrito por Michael DeMarco, therapist

Michael DeMarco, therapist

Psychedelic therapist, clinical sexologist, and Founding Fellow of Psychedelic Institute of Mental Health and Family Therapy

https://psychedelicmentalhealth.net/michael-demarco-therapist

A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review (Wong, et al, 2024)

Ketamine Use for Palliative Care in the Austere Environment: Is Ketamine the Path Forward for Palliative Care (Reed, et al, 2024)